OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.070
+0.040 (3.88%)
At close: Nov 20, 2024, 4:00 PM
1.099
+0.029 (2.72%)
After-hours: Nov 20, 2024, 7:41 PM EST
OKYO Pharma Employees
OKYO Pharma had 3 employees as of March 31, 2024. The number of employees decreased by 5 or -62.50% compared to the previous year.
Employees
3
Change (1Y)
-5
Growth (1Y)
-62.50%
Revenue / Employee
n/a
Profits / Employee
-$5,608,487
Market Cap
36.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
HOOKIPA Pharma | 179 |
Barinthus Biotherapeutics | 130 |
Carisma Therapeutics | 107 |
Adagio Medical Holdings | 85 |
Surrozen | 42 |
Citius Pharmaceuticals | 22 |
Eterna Therapeutics | 8 |
OKYO News
- 5 days ago - MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 4 weeks ago - OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain - GlobeNewsWire
- 3 months ago - OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 3 months ago - OKYO Pharma CEO Interview to Air on Bloomberg TV - GlobeNewsWire
- 3 months ago - OKYO Pharma Announces Chairman Acquires Shares - GlobeNewsWire
- 3 months ago - OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 3 months ago - OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use - GlobeNewsWire
- 4 months ago - OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101 - GlobeNewsWire